- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02051816
Facilitating EndotracheaL Intubation by Laryngoscopy Technique and Apneic Oxygenation Within the Intensive Care Unit: The FELLOW Study (FELLOW)
19. april 2017 oppdatert av: David Janz, Vanderbilt University
Facilitating EndotracheaL Intubation by Laryngoscopy Technique and Apneic Oxygenation Within the Intensive Care Unit
Respiratory failure requiring endotracheal intubation occurs in as many as 40% of critically ill patients.
Procedural complications including failed attempts at intubation, esophageal intubation, arterial oxygen desaturation, aspiration, hypotension, cardiac arrest, and death are common in this setting.
While there are many important components of successful airway management in critical illness, the maintenance of adequate arterial hemoglobin saturation from procedure initiation until endotracheal tube placement is paramount as desaturation is the most common factor associated with peri-intubation cardiac arrest and death.
Interventions that either shorten the duration of time required for tube placement or prolong the period before desaturation may be effective in improving outcome.
The high rate of complications and the lack of existing evidence regarding the efficacy of current airway management techniques in shortening the time to airway establishment or prolonging the time to desaturation mandates further investigation.
The primary hypothesis is that video laryngoscopy will be superior to direct laryngoscopy in successful first attempt at endotracheal intubation (defined by confirmed placement of an endotracheal tube in the trachea during first laryngoscopy attempt) of medical ICU patients by Pulmonary/Critical Care Medicine fellows after controlling for the operator's past number of procedures with the equipment used.
Also, the investigators hypothesize that the provision of apneic oxygenation during the endotracheal intubation procedure (defined as a nasal cannula with 15 liters per minute of oxygen flow placed prior to sedation or neuromuscular blockade and maintained until after completion of the procedure) will result in a higher arterial oxygen saturation nadir (defined as lowest noninvasive oxygenation saturation value observed between the administration of sedation and/or neuromuscular blockade and 2 minutes after successfully secured airway or death) compared to no apneic oxygenation.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Faktiske)
150
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Tennessee
-
Nashville, Tennessee, Forente stater, 37232
- Vanderbilt University Medical Center
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Adults
- Medical ICU Patients
- Require endotracheal intubation
- Endotracheal intubation to be performed by Pulmonary/Critical Care Medicine Fellow
- Sedation and/or neuromuscular blockade is planned for the procedure
Exclusion Criteria:
- Operators other than Pulmonary/Critical Care Medicine Fellows
- The operator predetermines that the patient requires specific intubating equipment or oxygenation technique will be required for the safe performance of the procedure
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Faktoriell oppgave
- Masking: Firemannsrom
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: VL and AO
Video laryngoscopy and apneic oxygenation
|
|
|
Aktiv komparator: DL and AO
Direct Laryngoscopy and apneic oxygenation
|
|
|
Aktiv komparator: VL and no AO
Video Laryngoscopy and no apneic oxygenation
|
|
|
Aktiv komparator: DL and no AO
Direct Laryngoscopy and no apneic oxygenation
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Successful First Attempt at Endotracheal Intubation (Defined by Confirmed Placement of an Endotracheal Tube in the Trachea During First Laryngoscopy Attempt) After Controlling for the Operator's Past Number of Procedures With the Equipment Used.
Tidsramme: 1 hour
|
The primary outcome for the video laryngoscopy compared with direct laryngoscopy arm of the study will be the successful first attempt at endotracheal intubation (defined by confirmed placement of an endotracheal tube in the trachea during first laryngoscopy attempt) after controlling for the operator's past number of procedures with the equipment used.
|
1 hour
|
|
Arterial Oxygen Saturation Nadir (Defined as Lowest Noninvasive Oxygenation Saturation Value Observed Between the Administration of Sedation and/or Neuromuscular Blockade and 2 Minutes After Successfully Secured Airway or Death).
Tidsramme: 1 hour
|
The primary outcome for the apneic oxygenation arm of the study is arterial oxygen saturation nadir (defined as lowest noninvasive oxygenation saturation value observed between the administration of sedation and/or neuromuscular blockade and 2 minutes after successfully secured airway or death).
|
1 hour
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Procedure-related Mortality
Tidsramme: 1 hour
|
Death within 1 hour of beginning the procedure
|
1 hour
|
|
ICU-mortality
Tidsramme: 28 days
|
Death from any cause in the ICU and at anytime after the procedure
|
28 days
|
|
Adjusted Lowest Arterial Oxygen Saturation During Procedure
Tidsramme: 1 hour
|
Arterial oxygen saturation nadir (defined as lowest noninvasive oxygenation saturation value observed between the administration of sedation and/or neuromuscular blockade and 2 minutes after successfully secured airway or death) adjusted for arterial oxygen saturation at the time of administering intubation drugs.
|
1 hour
|
|
Ventilator-free Days
Tidsramme: 28 days
|
Number of days alive and free of mechanical ventilation after endotracheal intubation
|
28 days
|
|
Number of Esophageal Intubations Per Group
Tidsramme: 1 hour
|
Number of esophageal intubations Per Study Group
|
1 hour
|
|
Grade View of the Glottis
Tidsramme: 1 hour
|
Best Cormack-Lehane grade view of the glottis (grade 1-4) on first laryngoscopy attempt.
Higher grades on the 1-4 scale indicate worse glottic views.
|
1 hour
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Matthew W Semler, MD, Vanderbilt University
- Studiestol: Todd W Rice, MD, MSc, Vanderbilt University
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. februar 2014
Primær fullføring (Faktiske)
1. februar 2015
Studiet fullført (Faktiske)
1. februar 2015
Datoer for studieregistrering
Først innsendt
27. januar 2014
Først innsendt som oppfylte QC-kriteriene
30. januar 2014
Først lagt ut (Anslag)
31. januar 2014
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
24. mai 2017
Siste oppdatering sendt inn som oppfylte QC-kriteriene
19. april 2017
Sist bekreftet
1. april 2017
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 131966
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .